Drawing for ANIMALCELLTHERAPIES

USPTO serial 86898168

ANIMALCELLTHERAPIES

Reviewed by CopyMark Law Group

Reg. 5224117Status 705Renewal
Filing date
Status date
Registration date
Jun 13, 2017
Examiner
KEAN, AMY C
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 705: Status 705 means a Madrid-based U.S. registration has accepted Section 71 maintenance and Section 15 incontestability. The U.S. extension is active with strengthened rights.

Need help with ANIMALCELLTHERAPIES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $650

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jeffrey Sheriff

Jeffrey Sheriff Pillsbury Winthrop Shaw Pittman LLP11682 El Camino Real, Suite 200SAN DIEGO, CA 92130United States

Goods and services

ClassDescriptionStatusFirst use
001Biological tissue, namely, blood, stem cells, umbilical cords and placentas for scientific and medical research use; cells for scientific, laboratory or medical research; laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use; stem cells for research or scientific research purposesSECTION 8 - CANCELLEDFeb 17, 2013
005Cells for medical or clinical use; Stem cells for medical or veterinary purposes; Pharmaceutical preparations for use in tissue engineered and cell based veterinary and medical therapies for use in the treatment of osteoarthritis, neurologic conditions, inflammatory conditions, immune- mediated conditions, endocrine diseases, chronic degenerative diseases, gastrointestinal diseases; Pharmaceutical preparations manufactured or modified by genetic engineering in the form of stem cells for veterinary and medical purposes; Pharmaceutical and veterinary preparations, namely, gene therapy products in the form of stem cells for therapeutic medical use; Biochemical preparations namely, preparations for use in gene therapy for the treatment of osteoarthritis, neurologic conditions, inflammatory conditions, immune-mediated conditions, endocrine diseases, chronic degenerative diseases, gastrointestinal diseases; Orthobiologic preparations, namely, biologic preparations in the nature of stem cells to achieve symptomatic relief and cures from various orthopedic diseasesSECTION 8 - CANCELLEDFeb 17, 2013
042Medical and scientific research services in the field of animal stem cells for research, diagnostic, and clinical use; biopharmaceutical development, research and evaluation services of stem cell-based therapeutics for the treatment of disease, injuries and disorders; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogeneticsACTIVEFeb 17, 2013

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 13, 2026REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Nov 15, 2024NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Nov 15, 2024C15PREGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Nov 12, 2024EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED—
Nov 1, 2024PC.DPETITION TO DIRECTOR DISMISSED—
Nov 1, 2024PR23POST REGISTRATION ACTION MAILED - SEC. 8 & 15—
Nov 1, 2024REINREINSTATED—
Oct 21, 2024APETASSIGNED TO PETITION STAFF—
Aug 30, 2024EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Aug 30, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 30, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 30, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 15, 2024TPDRTEAS PETITION TO DIRECTOR RECEIVED—
Aug 10, 2024NCS8NOTICE OF CANCELLATION SEC. 8 EMAILED—
Aug 10, 2024C8..CANCELLED SEC. 8 (6-YR)—
Dec 12, 2023PR23POST REGISTRATION ACTION MAILED - SEC. 8 & 15—
Nov 17, 2023APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
May 22, 2023E815TEAS SECTION 8 & 15 RECEIVED—
Sep 5, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 5, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 5, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 13, 2022REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jun 13, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 9, 2017SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
May 8, 2017CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Apr 22, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 21, 2017SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Apr 21, 2017EX1GSOU EXTENSION 1 GRANTED—
Apr 20, 2017AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Apr 11, 2017IUAFUSE AMENDMENT FILED—
Apr 11, 2017EXT1SOU EXTENSION 1 FILED—
Apr 11, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 11, 2017EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Oct 11, 2016NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 16, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 16, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 27, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 6, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 6, 2016XAECEXAMINER'S AMENDMENT ENTERED—
Jul 6, 2016GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jul 6, 2016GNEAEXAMINERS AMENDMENT E-MAILED—
Jul 6, 2016CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 2, 2016GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 2, 2016GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 2, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 19, 2016DOCKASSIGNED TO EXAMINER—
Feb 11, 2016MDSMNOTICE OF DESIGN SEARCH CODE E-MAILED—
Feb 10, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 8, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance